Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0000950170-25-010116

Chief Commercial Officer sold 1,583 shares at $7.87 ($12,461)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Powl Brian T. Chief Commercial Officer 2025-01-28 Sale −1,583 $7.87 $12,461 59,667 D: show line 1 in the form
Open-market sales · 1,583 sh · avg $7.87 · $12,461
Loading xslF345X05/ownership.xml…